Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
FDA Approves Generic Versions of Antidepressant Cymbalta
The first generic versions of the antidepressant Cymbalta have
been approved by the U.S. Food and Drug Administration.
The agency okayed six generic versions of the drug from a number
of companies, including Teva Pharmaceuticals, Sun Pharma Global and
Dr. Reddy's Laboratories Ltd., the
Cymbalta, the fifth best selling medication in the world in
2012, is marketed by Eli Lilly & Co. Inc. The company's patent
on Cymbalta expired Wednesday. Generic drugs typically sell for
much less than the original branded product.
Along with depression, Cymbalta is also used to treat
generalized anxiety disorder, fibromyalgia, diabetic nerve pain,
and some types of chronic pain, the
Female Libido Drug Maker Appealing FDA Decision
It's not clear whether the benefits of a drug meant to increase
sexual desire in women outweigh the risks, the U.S. Food and Drug
The agency considers the effectiveness of Sprout
Pharmaceuticals' drug flibanserin to be "modest," while side
effects include fatigue, dizziness and nausea, the
The daily pill was developed to boost libido in women by
targeting brain chemicals linked to mood and appetite.
An October letter from the FDA to Sprout denied approval of the
drug and requested more information. The company is appealing the
decision, but it appears to have a low chance of success. Only 3 of
17 appeals considered last year by the FDA were successful, the
So far, all attempts to develop a drug to increase women's
sexual desire have been unsuccessful.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.